Oncology Clinical Development: Oncology Expertise Across Cell & Gene Therapies, Biologics, And Small Molecules

As a full-service oncology CRO, IQVIA Biotech is dedicated to supporting biotech and emerging biopharma companies through every phase of development. Our extensive oncology expertise, coupled with an end-to-end approach, helps accelerate your clinical programs. With deep expertise across solid tumors, hematologic malignancies, and immuno-oncology, IQVIA Biotech supports trials involving cutting-edge treatments like CAR-T and CAR-NK therapies, bispecific antibodies, gene therapies, and oncolytic viruses. Through a global network, precision site selection, and advanced data handling, we enable faster, more efficient trial execution. With experience in over 500 oncology trials across a wide range of tumor types and rare diseases, IQVIA Biotech is positioned as a biotech-focused contract research organization (CRO) committed to accelerating oncology breakthroughs.